A synthetic lipopolysaccharide-binding peptide based on the neutrophil- derived protein CAP37 prevents endotoxin-induced responses in conscious rats

Infection and Immunity

Volumn 65, Issue 7, 1997, Pages 2803-2811

  Brackett, Daniel J ^a,b,c   Lerner, Megan R ^a,c   Lacquement, Melissa A ^a   He, Rong ^a   Pereira, H Anne ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; ESCHERICHIA COLI ENDOTOXIN;

ANIMAL MODEL; ARTICLE; ENDOTOXEMIA; ESCHERICHIA COLI; GRAM NEGATIVE SEPSIS; HYPERLACTATEMIA; LETHALITY; LEUKOPENIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SHOCK;

EID: 0030994620     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.7.2803-2811.1997     Document Type: Article

References (75)

1. Ammons, W. S., and H. C. Kung. 1993. Recombinant amino terminal fragment of bactericidal/permeabilily-increasing protein prevents hemodynamic responses to endotoxin. Circ. Shock 41:176-184.
2. Bauss, F., W. Dröge, and D. N. Männel. 1987. Tumor necrosis factor mediates endotoxic effects in mice. Infect. Immun. 55:1622-1625.
3. Bengtson, A., G. K. Hansson, and M. Heideman. 1987. In vivo determination of modulated migration of radiolabeled leukocytes. Arch. Surg. 122:909-912.
4. Beutler, B., and A. Cerami. 1986. Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation. Immunol. Res. 5:281-243.
5. Biber, B., C. F. Schaefer, M. J. Smolik, M. C. Lawrence, M. R. Lerner, D. J. Brackett, M. F. Wilson, and L. Fagraeus. 1987. Dose-related effects of isoflurane on superior mesenteric vasoconstriction induced by endotoxemia in the rat. Acta Anaesthesiol. Scand. 31:430-447.
6. Brackett, D. J., C. F. Schaefer, P. Tompkins, L. Fagraeus, L. J. Peters and M. F. Wilson. 1985. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ. Shock 17:273-284.
7. Brackett, D. J., M. R. Lerner, M. A. Duerr, A. K. Balla, D. V. Gauvin, F. A. Holloway, and M. F. Wilson. 1993. The effect of ethanol on cardiovascular, metabolic, and pathologic responses induced hy endotoxin. FASEB J. 7:2432.
8. Brackett, D. J., D. V. Gauvin, M. R. Lerner, F. A. Holloway, and M. F. Wilson. 1994. Dose- and time-dependent cardiovascular responses induced by ethanol. J. Pharmacol. Exp. Ther. 268:78-84.
9. Brogden, K. A., and M. Phillips, 1988. The ultrastructural morphology of endotoxins and lipopolysaccharides. Electron Microsc. Rev. 1:261-277.
10. Cannon, J. G., R. G. Tompkins, J. A. Gelfand, H. R. Michie, G. G. Stanford, H. W. M. van der Meer, S. Endres. G. Lonnemann, J. Corsetti, B. Chernow, D. W. Wilmore, S. M. Wolff, J. F. Burke, and C. A. Dinarello. 1990. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161:79-84.
11. Cody, C. S., R. S. Burd, J. K. Mayoral, and D. L. Dunn. 1992. Protective antilipopolysaccharide monoclonal antibodies inhibit tumor necrosis factor production. J. Surg. Res. 52:314-314.
12. Coran, A. G., R. A. Drongowski, J. J. Paik, and D. H. Remick. 1992. Ibuprofen intervention in canine septic shock: reduction of pathophysiology without decreased cytokines. J. Surg. Res. 53:272-279.
13. Danner, R. L., R. J. Elin, J. M. Hosseini, R. A. Wesley, J. M. Reilly, and J. E. Parrillo. 1491. Endotoxemia in human septic shock. Chest 99:164-175.
14. Flynn, P. M., J. L. Shenep, F. Gigliotti, D. S. Davis, and W. K. Hildner. 1988. Immunolabeling of lipopolysaccharide liberated from antibiotic-treated Escherichia coli. Infect. Immun. 56:2760-2762.
15. Fujihara, Y., W. C. Bogard, M.-G. Lei, P. E. Daddona, and D. C. Morrison. 1993. Monoclonal anti-lipid A IgM antibodies HA-1A and E-5 recognize distinct epitopes on lipopolysaccharide and lipid A. J. Infect. Dis. 168:1429-1435.
16. Galanos, C., O. Luderitz, E. T. Rietschel, O. Westphal, H. Brade, L. Brade, M. Freudenberg, U. Schade, M. Imoto, H. Yoshimura, S. Kusumoto, and T. Shiba. 1985. Synthetic and natural Escherihia coli free lipid A express identical endotoxin activities. Eur. J. Biochem. 145:1-5.
17. Galanos, C., and M. A. Freudenberg. 1993. Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunology 187:346-356.
18. Gudmundsson, S., and W. A. Craig. 1986. Role of antibiotics in endotoxin shock, p. 238-263. In R. A. Proctor (ed.), Handbook of endotoxin. Elsevier Biomedical Press B.V., Amsterdam, The Netherlands.
19. Hayes, W. H. 1981. Statistics, 3rd ed., p. 713. Holt, Rinehart, and Winston, Boston, Mass.
20. Issekutz, A. C., and S. Bhimji. 1982. Role for endotoxin in the leukocyte infiltration accompanying Eschericha coli inflammation. Infect. Imnum, 36:558-566.
21. Jin, H., R. Yang, S. Marsters, A. Ashkenazi, S. Bunting, M. N. Marra, R. W. Scott, and J. B. Baker. 1995. Protection against endotoxin shock by bactericidal/penneability-increasing protein in rats. J. Clin. Invest. 95:1947-1452.
22. Johnston, T. D., W. H. Hampton, and D. E. Fry. 1989. Septic hemodynamics produced by infusion of endotoxin. Curr. Surg. 46:101-103.
23. Kirk, R. E. 1986. In Experimental design, 2nd ed., p. 911. Brooks and Cole, Belmont, Calif.
24. Kohn, F. R., W. S. Ammons, A. Horwitz, L. Grinna, G. Theofan, J. Weickmann, and A. H. Kung. 1993. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia. J. Infect. Dis. 169:1307-1310.
25. Kuho, K., T. Kobayashi, T. Hayano, T. Koizumi, T. Honda, M. Sekiguchi, and A. Sakai. 1994. Effects of ONO-5046, a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep. J. Appl. Physiol. 77:1333-13411.
26. Kurost, I., M. Suematsu, S. Miura, D. Fukumura, E. Sekizuka, H. Nagata, C. Oshil, and M. Tsuchiya. 1993. Oxyradical generation from leukocytes during endotoxin-induced microcirculatory disturbance in rat mesentery - attenuating effect of cetraxate. Toxicol. Appl. Pharmacol. 120:37-44.
27. Lang, C. L., J.-C. A. Obih, G. J. Bugby, J. N. Bagwell, and J. J. Spitzer. 1991. Endotoxin-induced increases in regional glucose utilization by small intestine: a TNF-independent effect. Am. J. Physiol. 260:548-555.
28. Lasfargues, A., M.-A. Tahri-Jouti, T. Pedron, R. Girard, and R. Chaby. 1989. Effects of lipopolysaceharide on macrophages analyzed with anti-lipid A monoclonal antibodies and polymyxin B. Eur. J. Immunol. 19:2219-2225.
29. Lin, R. Y., M. E. Astiz., J. C. Saxon, D. C. Saha, and E. C. Rackow. 1994. Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit. Care Med. 22:1595-1602.
30. Martich, G. D., R. L. Danner, M. Ceska, and A. F. Suffredini. 1991. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J. Exp. Med. 173:1021-1024.
31. Martich. G. D., M. M. Parker, R. E. Cunnion, and A. F. Suffredini. 1992. Effects of human and pentoxifylline on the cardiovascular response of normal humans to endotoxin. J. Appl. Physiol. 73:925-931.
32. Merrifield, K. N. 1986. Solid phase synthesis. Science 232:341-347.
33. Michie, H. R., D. R. Springs, K. R. Manogue, M. L. Sherman, A. Revhaug, S. T. O'Dwyer, K. Arthur, C. A. Dinarello, A. Cerami, S. M. Wolff, D. W. Kufe, and D. W. Wilmore. 1988. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104:280-286.
34. Michie, H. R., K. R. Manogue, D. R. Spriggs, A. Revhaug, S. O'Dwyer, C. A. Dinarello, A. Cerami, S. M. Wolff, and D. W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
35. Moore, F. D., S. H. Socher, and C. Davis. 1991. Tumor necrosis factor and endotoxin can cause neutrophil activation through separate pathways. Arch. Surg. 126:70-73.
36. Morgan, J. G., T. Sukiennicki, H. A. Pereira, J. K. Spitznagel, M. E. Guerra, and J. W. Larrick. 1991. Cloning of the cDNA for the serine protease homolog CAP37/azurocidn, a microbicidal and chemotactic protein from human granulocytes. J. Immunol. 147:3210-3214.
37. Morrison, D. C., and R. J. Ulevitch. 1978. The effects of bacterial endotoxins on host mediation systems. Am. J. Pathol. 93:526-617.
38. Movat, H. Z. 1987. Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury. J. Lab. Clin. Med. 110:668-681.
39. Mozes, T., S. Ben-Efraim, C. J. A. Tak, J. P. C. Heiligers, P. R. Saxena, and I. L. Bonta. 1901. Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock. Immunol. Lett. 27:157-162.
40. Myers, J. L. 1979. Fundamentals of experimental design, 3rd ed., p. 556. Allyn and Bacon, Boston, Mass.
41. Noronna-Blob, L., V. C. Lowe, M. Weitzberg, and R. M. Burch. 1991. NPC 15669 enhances survival and reverses leukopenia in endotoxin-treated mice. Eur. J. Pharmacol. 199:387-388.
42. Nowotny, A. 1987. Review of the molecular requirements of endotoxin actions. Rev. Infect. Dis. 9(Suppl. 5):5503-5511.
43. Nys, M., J. M. Cloes, J. Demonty, and L. Jonssin. 1990. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia. J. Infect. Dis. 162:1087-1095.
44. Parent, J. B., H. Gazzano-Santorn, D. M. Wood, E. Lim, P. T. Pruyne, P. W. Trown, and P. J. Conion. 1992. Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides. Circ. Shock. 38:63-73.
45. Pedron, T., R. Girard, A. Lasfargues, and R. Chaby. 1993. Differential effects of a monoclonal antibody recognizing 3-deoxy-D-manno-2-octulosonic acid on endotoxin induced activation of pre-B cells and macrophages. Cell. Immunol. 148:18-31.
46. Perdra, H. A., I. Erdem, J. Pohl, and J. K. Spitznagel. 1993. Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein. Proc. Natl. Acad. Sci. USA 90:4733-4737.
47. Pieroni, R. E., E. J. Broderick, A. Bundeally, and L. Levine. 1970. A simple method for the quantitation of submicrogram amounts of bacterial endotoxin. Proc. Soc. Exp. Med. Biol. 133:700-704.
48. Pohi, J., H. A. Pereira, N. M. Martin, and J. K. Spitznagel. 1990. Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase. FBBS Lett. 272:200-204.
49. Raetz, C. R. H. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59:129-170.
50. Redl, H., G. Schlag, S. Bahrami, J. Davies, M. Jochum, and A. Bengtsson. 1994. Experimental and clinical evidence of leukocyte activation in trauma and sepsis. Prog. Clin. Biol. Res. 388:221-245.
51. Rietschel, E. T. 1984. Chemistry of endotoxin. Handb. Endotoxin 1:187-214.
52. Rietschel, E. T., H. Brade, L. Brade, K. Brandenburg, F. U. Schade, U. Seydelf U. Zubringer, C. Galanos, O. Luderitz, O. Westphal, H. Labischinski, W. Kusumoto, and T. Shiba. 1987. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog. Clin. Biol. Res. 231:25-53.
53. Rietschel, E. T., L. Brade, U. F. Schade, U. Seydel, U. Zahringer, and H. Brade. 1994. Bacterial endotoxins: properties and structure of biologically active domains, p. 1-41. In E. Schrinner, M. Richmond, G. Seibert, and U. Schwarz (ed.), Surface structures of microorganisms and their interaction with the mammalian host. Verlag Chemie, Weinheim, Germany.
54. Sanchez-Cantu, L., H. N. Rode, T. J. Yun, and N. V. Christou. 1991. Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide. Arch. Surg. 126:231-235.
55. Schaefer, C. F., D. J. Brackett, P. Tompkins, and M. F. Wilson. 1984. Anesthetic-induced changes in cardiovascular and small intestinal responses to endotoxin in the rat. Adv. Shock Res. 10:125-133.
56. Schaefer, C. F., B. Biber, D. J. Brackett, C. C. Schmidt, L. Fagraeus, and M. F. Wilson. 1987. Choice of anesthetic alters the circulatory shock pattern as gauged by conscious rat endotoxemia. Acta Anaesthesiol. Scand. 31:550-556.
57. Shafer, W. M., L. E. Martin, and J. K. Spitznagel. 1984. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect. Immun. 45:20-35.
58. Shafer, W. M., L. E. Martin, and J. K. Spitznagel. 1986. Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granules. Infect. Immun. 53:651-655.
59. Shenep, J. L., P. M. Flynn, F. F. Barrett, G. L. Stidham, and D. F. Westenkirchner. 1988. Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J. Infect. Dis. 157:565-568.
60. Shimamoto, Y., R. L. Chen, A. Bollon, A. Chang, and A. Khan. 1988. Monoclonal antibodies against human recombinant tumor necrosis factor: prevention of endotoxic shock. Immunol. Lett. 17:311-318.
61. Sigurdsson, G. H., J. T. Christenson, M. al-Mousawi, and A. Owumwanne. 1989. Use of indium-111 oxine to study pulmonary and hepatic leukocyte sequestration in endotoxin shock and effects of the beta-2 receptor agonist terbutaline. Am. J. Physiol. Imaging 4:136-142.
62. Silva, A. T., B. J. Appelmelk, W. A. Buurman, K. F. Bayston, and J. Cohen. 1990. Monoclonal antibody to endotoxin core protects mice from Escherichia coli sepsis by a mechanism independent of tumor necrosis factor and interleukin-6. J. Infect. Dis. 162:454-459.
63. Stumacher, R. J., M. J. Kovnat, and W. R. McCabe. 1973. Limitations of the usefulness of the Limulus assay for endotoxin. N. Engl. J. Med. 288:1261-1264.
64. Suffredini, A. F., P. C. Harpel, and J. E. Parrillo. 1989. The promotion and subsequent inhibition of plasminogen following intravenous endotoxin administration to normal humans. N. Engl. J. Med. 320:1165-1172.
65. Suffredini, A. F., R. E. Fromm, M. M. Parker, M. Brenner, J. A. Kovacs, R. A. Wesley, and J. E. Parrillo. 1989. The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321:280-287.
66. Tahri-Jouti, M.-A., M. Mondange, A. Le Dur, E. I. Auzanneau, D. Charon, R. Girard, and R. Chaby. 1990. Specific binding of lipopolysaccharides to mouse macrophages. II. Involvement of distinct lipid A substructures. Mol. Immunol. 27:763-770.
67. Taveira da Silva, A. M., H. C. Kaulbach, F. S. Chuidian, D. R. Lambert, A. F. Suffredini, and R. L. Danner. 1993. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N. Engl. J. Med. 328:1457-1460.
68. Toft, P., S. T. Lillevang, E. Tonnesen, P. Svendsen, and K. Hohndorf. 1993. Redistribution of lymphocytes following E. coli sepsis. Scand. J. Immunol. 38:541-545.
69. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kue, W. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664.
70. Uleviteh, R. J. 1991. Recognition of bacterial endotoxin in biologic systems. Lab. Invest. 65:121-122.
71. vanDeventer, S. J. H., H. R. Buller, J. W. ten Cate, A. Sturk, and W. Pauw. 1988. Endotoxemia: an early predictor of septicaemia in febrile patients. Lancet 1:605-608.
72. Wakefield, C. H., P. D. Carey, S. Foulds, J. R. Monson, and P. J. Guillou. 1993. Polymorphonuclear leukocyte activation. An early marker of the post-surgical sepsis response. Arch. Surg. 128:390-395.
73. Warren, H. S., M. L. Glennon, N. Wainwright, S. F. Amato, K. M. Black, S. J. Kirsch, G. R. Riveau, R. I. Whyte, W. M. Zapol, and T. J. Novitsky. 1992. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor. Infect. Immun. 60:2506-2513.
74. Warren, H. S., S. F. Amato, C. Filling, K. M. Black, P. M. Loiselle, M. S. Pasternack, and J.-M. Cavaillon. 1993. Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J. Exp. Med. 177:89-97.
75. Winer, B. J. 1971. Statistical principles in experimental design, 2nd ed., p. 435. McGraw-Hill, New York, N.Y.